MedDataX Logo

Eye Diseases "Treated" with Interoperable Medical Informatics

NCT ID: NCT06810011

Last Updated: 2025-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-01

Study Completion Date

2028-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overarching goal of EyeMatics is to promote an interoperable, sustainable infrastructure for the integration and sharing of data from clinical research to improve personalized medicine in ophthalmology. To achieve this, EyeMatics bundles the expertise and preliminary work of the four consortia of the Medical Informatics Initiative (MII) and the ophthalmological centers of excellence in Germany. The perspective and concerns of patients will be strongly incorporated into the project work through close cooperation with patient representatives and the inclusion of patient feedback on quality of life and treatment success.

EyeMatics aims to improve the understanding of the therapeutic success of eye diseases that are usually treated with intravitreal surgical medication (IVOM). To this end, an exemplary analysis platform for "real" clinical data will be provided and a dashboard for data visualization and analysis will be developed as a web application. The dashboard is to be introduced at all participating hospital sites for research purposes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Usability User Testing of the Easy-EyeFM AI Platform

NCT06834906

Ocular Diseases
RECRUITING NA

Evaluation of The Performance of Retinow AI Software

NCT06645964

Diabetic Retinopathy Glaucoma Macular Degeneration
COMPLETED

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression

NCT05698316

Age Related Macular Degeneration Intermediate AMD Atrophy +1 more
ACTIVE_NOT_RECRUITING

Retinal Care Data Repository

NCT04794907

Diabetic Retinopathy Age Related Macular Degeneration
NOT_YET_RECRUITING

Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening

NCT06879834

Diabetic Retinopathy
RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intravitreal Injections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* OPS code: "5-156.9 Injection of drugs into the posterior segment of the eye"
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Medicine Greifswald

OTHER

Sponsor Role collaborator

University Medical Center Mainz

OTHER

Sponsor Role collaborator

University Hospital, Aachen

OTHER

Sponsor Role collaborator

Klinikum Chemnitz gGmbH

OTHER

Sponsor Role collaborator

Technische Universität Dresden

UNKNOWN

Sponsor Role collaborator

University of Leipzig

OTHER

Sponsor Role collaborator

University Hospital Tuebingen

OTHER

Sponsor Role collaborator

Deutsche Ophthalmologische Gesellschaft e.V.

UNKNOWN

Sponsor Role collaborator

Pro Retina Deutschland e.V.

UNKNOWN

Sponsor Role collaborator

University Hospital Muenster

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nicole Eter

Univ.-Prof. Dr. med. Nicole Eter

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Klinikum Chemnitz gGmbH

Chemnitz, Saxony, Germany

Site Status RECRUITING

Universitätsklinikum Aachen, AöR

Aachen, , Germany

Site Status RECRUITING

Universitätsmedizin Greifswald

Greifswald, , Germany

Site Status RECRUITING

Universität Leipzig

Leipzig, , Germany

Site Status RECRUITING

Universität Münster

Münster, , Germany

Site Status RECRUITING

Universitätsklinikum Tübingen

Tübingen, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nicole Eter, Prof. Dr.

Role: CONTACT

[email protected]
00492518356004

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vinodh Kakkassery, Prof. Dr.

Role: primary

[email protected]
0049371 33337050

Peter Walter, Univ.-Prof. Dr.

Role: primary

[email protected]
0049241 8088191

Andreas Stahl, Univ.-Prof. Dr.

Role: primary

[email protected]
00493834 86-5900

Focke Ziemssen, Univ.-Prof. Dr.

Role: primary

[email protected]
0049 341 97 21650

Nicole Eter, Univ.-Prof. Dr.

Role: primary

[email protected]
0049 251 83 56004

Karl Ulrich Bartz-Schmidt, Univ.-Prof. Dr.

Role: primary

[email protected]
00497071 2925092

References

Explore related publications, articles, or registry entries linked to this study.

Holtrup L, Varghese J, Schuster AK, Poschkamp B, Hampf C, Waltemath D, Wahle L, Lipprandt M, Merle DA, Berens P, Kohlbacher O, Kakkassery V, Bartos M, Ziemssen F, Wendt T, Hoffmann K; EyeMatics Study Group; Eter N. [EyeMatics-Multicenter data evaluation of real-world data with interoperable medical informatics]. Ophthalmologie. 2025 Apr;122(4):270-277. doi: 10.1007/s00347-024-02135-0. Epub 2024 Nov 14. German.

Reference Type BACKGROUND
PMID: 39542916 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

01ZZ2319A-I

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

01ZZ2319A-I

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.
NCT07308639 NOT_YET_RECRUITING
Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images
NCT06213896 COMPLETED
Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
NCT06351657 RECRUITING
oCular Examination at Cell RESolution With Optical TransmissionTomography
NCT06976034 RECRUITING NA
Verisee Software for Diabetic Retinopathy Screening
NCT04631653 UNKNOWN NA
Building Research With Artificial Intelligence in Neuro-Ophthalmology
NCT06390579 COMPLETED
High Resolution, High-speed Multimodal Ophthalmic Imaging
NCT04129021 RECRUITING NA
Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application
NCT03899623 UNKNOWN
AI Classifies Multi-Retinal Diseases
NCT04592068 UNKNOWN
Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
NCT06893965 RECRUITING NA
Personalized Shared Eye-care Identification of Age-related Macular Degeneration Using Artificial Intelligence and Telemedicine by Matching Optometrist Office-based Sites With Clinical Supervision
NCT06465212 NOT_YET_RECRUITING
Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics
NCT07069647 RECRUITING NA
High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV)
NCT03070717 COMPLETED
Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD
NCT04676854 ACTIVE_NOT_RECRUITING NA
Ophthalmic AI-Assisted Medical Decision-Making
NCT06755060 RECRUITING NA
Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases
NCT07143851 NOT_YET_RECRUITING
Therapy of Age-related Macular Degeneration
NCT05222997 UNKNOWN
OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases
NCT05752045 UNKNOWN NA
ARTIFICIAL INTELLIGENCE FOR MASS SCREENING OF THE DIABETIC RETINOPATHY IN THE CHERNIVTSI REGION (Pilot Study)
NCT06112691 UNKNOWN
Development and Validation of the Observatory Battery of Common Eye Disorders for Adults With Intellectual Disability
NCT06737627 RECRUITING
Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
NCT06351670 RECRUITING
Identification of Cellular Biomarkers of Rare Eye Diseases in Adults
NCT07063719 NOT_YET_RECRUITING NA
Ocular, Vascular, and Genetic Findings in AMD Patients
NCT06015633 ACTIVE_NOT_RECRUITING
Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in Germany
NCT01448538 COMPLETED
National Eye Institute Biorepository for Retinal Diseases
NCT01496625 RECRUITING